Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Author:
Publisher
Elsevier BV
Subject
Clinical Neurology
Reference37 articles.
1. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010;Vos;Lancet,2012
2. Defining the differences between episodic migraine and chronic migraine;Katsarava;Curr Pain Headache Rep,2012
3. The International Classification of Headache Disorders, 3rd edition (beta version);Cephalalgia,2013
4. Quality-of-life differences between patients with episodic and transformed migraine;Meletiche;Headache,2001
5. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life;Buse;Mayo Clin Proc,2009
Cited by 578 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Drug-related side effects and adverse reactions in the treatment of migraine: a bibliometric and visual analysis;Frontiers in Neurology;2024-02-06
2. Posttraumatic headache is a distinct headache type from migraine;Current Opinion in Neurology;2024-02-01
3. Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI study;The Journal of Headache and Pain;2024-01-09
4. Adverse event reporting of four anti-Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: a real-world study based on the FDA adverse event reporting system;Frontiers in Pharmacology;2024-01-09
5. Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab;European Journal of Hospital Pharmacy;2024-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3